Here are the latest quarterly results of BERYL DRUGS. For more details, see the BERYL DRUGS financial fact sheet and BERYL DRUGS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 35 | 50 | 79 | 82 | 61 | 82 | 81 | 77 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Turnover | Rs m | 35 | 50 | 79 | 82 | 61 | 82 | 81 | 77 | |
Expenses | Rs m | 38 | 44 | 73 | 75 | 58 | 70 | 74 | 69 | |
Gross profit | Rs m | -3 | 6 | 6 | 7 | 3 | 11 | 7 | 8 | |
Depreciation | Rs m | 3 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | |
Interest | Rs m | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Profit before tax | Rs m | -7 | 2 | 3 | 4 | 1 | 7 | 3 | 4 | |
Tax | Rs m | -2 | 0 | -0 | 2 | -0 | 2 | 1 | 1 | |
Profit after tax | Rs m | -5 | 2 | 3 | 1 | 1 | 5 | 3 | 3 | |
Gross profit margin | % | -8.2 | 12.0 | 8.0 | 8.7 | 4.5 | 13.9 | 8.9 | 10.4 | |
Effective tax rate | % | 28.0 | 1.8 | -5.5 | 62.2 | -5.0 | 27.3 | 15.9 | 17.3 | |
Net profit margin | % | -13.5 | 4.4 | 4.3 | 1.7 | 1.0 | 6.5 | 3.4 | 4.0 | |
Diluted EPS | Rs | -0.9 | 0.4 | 0.7 | 0.3 | 0.1 | 1.0 | 0.5 | 0.6 | |
Diluted EPS (TTM) | Rs | -1.3 | -1.5 | -0.0 | 0.5 | 1.5 | 2.1 | 2.0 | 2.3 | |
Subscriber Feature |
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.